These compounds act as irreversible or reversible LSD1 inhibitors with various degrees of specificity and display in vitro efficacy in AML with the inhibition of cell proliferation and induction of cell differentiation [67,68]. The gene discussed is KDM1A; the disease is acute myeloid leukemia.